M&A Deal Summary

Perrigo Company Acquires KV Pharmaceutical - ANDA

On September 21, 2009, Perrigo Company acquired medical products company KV Pharmaceutical - ANDA from KV Pharmaceutical for 14M USD

Acquisition Highlights
  • This is Perrigo Company’s 5th transaction in the Medical Products sector.
  • This is Perrigo Company’s 21st largest (disclosed) transaction.
  • This is Perrigo Company’s 5th transaction in the United States.
  • This is Perrigo Company’s 1st transaction in Missouri.

M&A Deal Summary
Date 2009-09-21
Target KV Pharmaceutical - ANDA
Sector Medical Products
Buyer(s) Perrigo Company
Sellers(s) KV Pharmaceutical
Deal Type Divestiture
Deal Value 14M USD

Target

KV Pharmaceutical - ANDA

Chesterfield, Missouri, United States
KV Pharmaceutical - ANDA comprises clindamycin phosphate (1%) and benzoyl peroxide (5%) gel. Duac gel, indicated for the topical treatment of inflammatory acne vulgaris.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Perrigo Company

Dublin 2, Ireland
Category Company
Founded 1887
Sector Life Science
Employees9,140
Revenue 4.7B USD (2023)
DESCRIPTION
Entrance to a Perrigo facility in Duncan, South Carolina.
Entrance to a Perrigo facility in Duncan, South Carolina.

Perrigo Company is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world's largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies. Perrigo Company was founded in 1887 and is based in Dublin, Ireland.

DEAL STATS #
Overall 10 of 31
Sector (Medical Products) 5 of 10
Type (Divestiture) 1 of 7
State (Missouri) 1 of 1
Country (United States) 5 of 18
Year (2009) 1 of 1
Size (of disclosed) 21 of 23
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-11-13 Unico Holdings

Lake Worth, Florida, United States

Unico Holdings, Inc. is an independent manufacturer of private label health and personal care products.

Buy $49M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-03-01 ORION Laboratories Pty

St Balcatta, Australia

Based at Balcatta in Western Australia, the ORION facility offers capability in the area of non-sterile manufacturing, specializing in cream and liquid fills. ORION also manufactures pessaries and suppositories.We manufacture and market an extensive range of ORION branded products including therapeutic pharmaceuticals such as prescription products, over-the-counter medicines, formulated devices, antiseptics and disinfectants.

Buy $48M

Seller(S) 1

SELLER

KV Pharmaceutical

Chesterfield, Missouri, United States
Category Company
Sector Life Science
DESCRIPTION

KV Pharmaceutical Co. engages in development, manufacturer, acquires and markets branded and generic/non-branded prescription pharmaceutical products.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (Missouri) 1 of 1
Country (United States) 1 of 1
Year (2009) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-22 Hologic - Gestiva

United States

Hologic - Gestiva is a drug, which could be used in the prevention of preterm birth in pregnant women with a history of at least one spontaneous preterm birth.

Buy $82M
Mergr

Product

Company

Legal